These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8005290)
1. Endometrial responses to three different progestins in artificial cycles: a prospective, crossover study. Li TC; Aplin JD; Warren A; Graham RA; Dockery P; Cooke ID Fertil Steril; 1994 Jul; 62(1):191-3. PubMed ID: 8005290 [TBL] [Abstract][Full Text] [Related]
2. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study. Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464 [TBL] [Abstract][Full Text] [Related]
3. Effect of Oral versus Vaginal Administration of Estradiol and Dydrogesterone on the Proliferative and Secretory Transformation of Endometrium in Patients with Premature Ovarian Failure and Preparing for Assisted Reproductive Technology. Feng W; Nie L; Wang X; Yang F; Pan P; Deng X Drug Des Devel Ther; 2021; 15():1521-1529. PubMed ID: 33883876 [TBL] [Abstract][Full Text] [Related]
4. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles. Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975 [TBL] [Abstract][Full Text] [Related]
5. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: a pilot randomised controlled trial. Karakus S; Kiran G; Ciralik H Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):685-8. PubMed ID: 20070724 [TBL] [Abstract][Full Text] [Related]
7. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium. Schindler AE Maturitas; 2009 Dec; 65 Suppl 1():S3-11. PubMed ID: 19969432 [TBL] [Abstract][Full Text] [Related]
8. Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17beta-oestradiol and 2.5mg dydrogesterone: protection of the endometrium and amenorrhoea rate. Bergeron C; Nogales FF; Rechberger T; Tatarchjuk T; Zipfel L Maturitas; 2010 Jun; 66(2):201-5. PubMed ID: 20378287 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles. Saharkhiz N; Zamaniyan M; Salehpour S; Zadehmodarres S; Hoseini S; Cheraghi L; Seif S; Baheiraei N Gynecol Endocrinol; 2016; 32(3):213-7. PubMed ID: 26486011 [TBL] [Abstract][Full Text] [Related]
16. Endometrial responses in artificial cycles: a prospective study comparing four different oestrogen dosages. Li TC; Cooke ID; Warren MA; Goolamallee M; Graham RA; Aplin JD Br J Obstet Gynaecol; 1992 Sep; 99(9):751-6. PubMed ID: 1329937 [TBL] [Abstract][Full Text] [Related]
17. Experience with a novel vaginal progesterone preparation in a donor oocyte program. Gibbons WE; Toner JP; Hamacher P; Kolm P Fertil Steril; 1998 Jan; 69(1):96-101. PubMed ID: 9457941 [TBL] [Abstract][Full Text] [Related]
18. Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques. Nadarajah R; Rajesh H; Wong KY; Faisal F; Yu SL Singapore Med J; 2017 Jun; 58(6):294-297. PubMed ID: 27090598 [TBL] [Abstract][Full Text] [Related]
19. Endometrial responses in artificial cycles: a prospective, randomized study comparing three different progesterone dosages. Li TC; Ramsewak SS; Lenton EA; Cooke ID; Warren MA; Dockery P Br J Obstet Gynaecol; 1992 Apr; 99(4):319-24. PubMed ID: 1581278 [TBL] [Abstract][Full Text] [Related]
20. Progesterone versus dehydrogesterone as replacement therapy in women with premature ovarian failure. Pellicer A; Matallín P; Miró F; Rivera J; Bonilla-Musoles FM Hum Reprod; 1989 Oct; 4(7):777-81. PubMed ID: 2606955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]